Schrodinger Taps Google Clouds High Performance Compute Solution to Bolster Its Drug Discovery Efforts

Schrodinger, Inc. announced it has entered into a three year agreement with Google Cloud to substantially increase the speed and capacity of its physics-based computational platform for drug...

Samsung Biologics $ STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug

Pharmaceutical industry in Russia, Ukraine and in other CIS countries can be considered one of the most complex industries with a view to the management of intellectual property...

Thermo Scientific new Vanquish Core HPLC Systems Delivers Productivity, Precision and Compliance in Routine Analyses

Thermo Scientific Vanquish Core HPLC Systems expand on the award-winning performance of the Vanquish platform to provide a productivity enhancing solution for routine laboratories.

Catalent Announces Supplying Blueprint Medicines Precision Therapy AYVAKIT

Catalent announcement by Blueprint Medicines Corporation that the U.S. FDA has approved AYVAKIT for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor (GIST)...

Merck working with EOS AMCM to produce next generation 3D printed tablets

Merc announced a cooperation agreement on the 3D printing of tablets. AMCM offers customized additive manufacturing solutions and is a sister company of 3D printing worldmarket leader EOS.

SmartLabs, a First of Its Kind Laboratory-as-a-Service, Expands Nationally with CA Location

SmartLabs, announced a national expansion with the addition of 80,000 square feet in South San Francisco, California. Building upon its continued success in Massachusetts, SmartLabs’s new San Francisco...

FDA approves GSKs Advil Dual Action with Acetaminophen for over the-counter use in the United States

GlaxoSmithKline announced that the U.S. FDA has approved Advil Dual Action with Acetaminophen as an over the counter product for pain relief. The exclusive formula is now the first FDA approved...

Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets

Abpro announced the formation of a strategic partnership to advance two bispecific antibodies in key Asian markets including China, Japan & South Korea.